Scientists at Columbia University’s Mortimer B. Zuckerman Mind Brain Behavior Institute have developed a new viral tool that dramatically expands scientists’ ability to probe the activity and circuitry of brain cells, or neurons, in the mouse brain.
Columbia Engineering researchers have shown, for the first time, that electrical stimulation of human heart muscle cells (cardiomyocytes) engineered from human stem cells aids their development and function.
The targeted cancer drug ibrutinib has recently transformed the treatment of chronic lymphocytic leukemia, adding years to the lives of patients with hard-to-treat disease who were told they had just months to live.
The Defense Advanced Research Projects Agency (DARPA) has established a new Electrical Prescriptions (ElectRx) program to help spur research in this area, with the goal to develop new technologies that could improve physical and mental health by using targeted stimulation of the peripheral nervous system to exploit the body’s natural ability to quickly and effectively heal itself.
Last year, three biomedical engineering (BME) MS students—Teresa Cauvel, Rebecca Peyser, and Sona Shah—took BME Lecturer Katherine E. Reuther’s new design course and came up with an idea for a health technology startup they called Neopenda.
Slowly, the ranks of New York biotechs are increasing, thanks in part to a growing group of early-stage venture capitalists dipping their toes in the local startup scene. Tara Biosystems is one of those startups, and today it’s brought a few new investors in as part of a plan to take root and grow in the city.
Scientists at Columbia University’s Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University Medical Center (CUMC), and the Université Paris Descartes have found that deficits in social memory may be due to a decrease in the number of a particular class of brain cells.